{
  "name": "Johnson & Johnson",
  "slug": "johnson-and-johnson",
  "ticker": "JNJ",
  "fetched_at": "2026-01-16T12:25:34.863410+00:00",
  "news": [
    {
      "title": "Johnson & Johnson's $1 billion loss from robotics takeover reduced by Delaware top court - Reuters",
      "link": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNMXlZSmI0X1ZwZHBGUG5mZ2pWVHFHZmJ1c0c1ZFRaN3hLX3J0MmhNODA3dlJSczZjYVRsaG9lYzhfdVhDVFhSMEJKUFQwcEROUF9NSGl1em5FUVgxemZWNFg2c3k4RkJSc3QxV3FEMDNsQnVuR2pxTkZvVmRfOE1yNklfUEQ1bDk5d1RjemdaTE1HbjU5amU3bVhpRmxsTlZzbmhrNzRwS21hajNjcWVHS2l2bXJ3OFdNbV9CTk5aR08yTENOSFhZOGNHYWU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMizAFBVV95cUxNMXlZSmI0X1ZwZHBGUG5mZ2pWVHFHZmJ1c0c1ZFRaN3hLX3J0MmhNODA3dlJSczZjYVRsaG9lYzhfdVhDVFhSMEJKUFQwcEROUF9NSGl1em5FUVgxemZWNFg2c3k4RkJSc3QxV3FEMDNsQnVuR2pxTkZvVmRfOE1yNklfUEQ1bDk5d1RjemdaTE1HbjU5amU3bVhpRmxsTlZzbmhrNzRwS21hajNjcWVHS2l2bXJ3OFdNbV9CTk5aR08yTENOSFhZOGNHYWU?oc=5\" target=\"_blank\">Johnson & Johnson's $1 billion loss from robotics takeover reduced by Delaware top court</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2026-01-13T00:56:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "After succeeding in combo with Darzalex, J&J's Tecvayli shines as solo act - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOSWVlaGxXN09EOVhCTXVVNG5HYmF0WHB0bEgwcmNxaEJ3aFd0SWNRSERsSWo5MHl4UGtrTmpzdTM4VzhheHRJWGZxU2J0cXNJNE9xMFNUMEdTY0hpYXU5TkRhY2Z4Nm9hcmhZSkVweXpRaEpMT2FKZFZKUnFpdDRUdEtJTVFETnFsRS1xQlJtWEVobTZ6YmZidFdDY3A?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMinAFBVV95cUxOSWVlaGxXN09EOVhCTXVVNG5HYmF0WHB0bEgwcmNxaEJ3aFd0SWNRSERsSWo5MHl4UGtrTmpzdTM4VzhheHRJWGZxU2J0cXNJNE9xMFNUMEdTY0hpYXU5TkRhY2Z4Nm9hcmhZSkVweXpRaEpMT2FKZFZKUnFpdDRUdEtJTVFETnFsRS1xQlJtWEVobTZ6YmZidFdDY3A?oc=5\" target=\"_blank\">After succeeding in combo with Darzalex, J&amp;J's Tecvayli shines as solo act</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2026-01-15T15:15:00+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "JPM26: J&J reveals oncology strategy - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMifEFVX3lxTFBVeDc3T1B2MVJDYy1CNlZUa1ZYOHduUGM0Z2Q0c3ExdTJ4TF9xd1Z0XzMzT0JIMVNwQTFNZnhlZ1BuUENiQVdWTHBwLWZzQzVvb0d3Q1ZjS3JSaFIyY3hDbGN0aTdpUC1aRUR2dTN4MUk4Ym1PTGRWdGtLMFY?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMifEFVX3lxTFBVeDc3T1B2MVJDYy1CNlZUa1ZYOHduUGM0Z2Q0c3ExdTJ4TF9xd1Z0XzMzT0JIMVNwQTFNZnhlZ1BuUENiQVdWTHBwLWZzQzVvb0d3Q1ZjS3JSaFIyY3hDbGN0aTdpUC1aRUR2dTN4MUk4Ym1PTGRWdGtLMFY?oc=5\" target=\"_blank\">JPM26: J&amp;J reveals oncology strategy</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2026-01-13T16:12:53+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Johnson & Johnson wins partial reversal of $1B Auris case loss - MassDevice",
      "link": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNblhGUndzaGJpU2EtemJ3VHI2WkIyd21HOXlFZmI4dkZqLTFOMF9SQkRBeGNsbWZPRWFVVG9pYnAtdXFWdDRUNGRKNnBFZkJMTFNnVXl2X3hXZ2R0S0p6dHpOQWUwVDh4MkUxZzJvemloVzJJM3R1SGpQSlhhMDMzTkZhbTBNYUZuUUEyLXNzU1k?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikAFBVV95cUxNblhGUndzaGJpU2EtemJ3VHI2WkIyd21HOXlFZmI4dkZqLTFOMF9SQkRBeGNsbWZPRWFVVG9pYnAtdXFWdDRUNGRKNnBFZkJMTFNnVXl2X3hXZ2R0S0p6dHpOQWUwVDh4MkUxZzJvemloVzJJM3R1SGpQSlhhMDMzTkZhbTBNYUZuUUEyLXNzU1k?oc=5\" target=\"_blank\">Johnson & Johnson wins partial reversal of $1B Auris case loss</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MassDevice</font>",
      "published": "2026-01-15T19:35:33+00:00",
      "source": "MassDevice"
    },
    {
      "title": "J&J builds case for earlier Tecvayli use in multiple myeloma - pharmaphorum",
      "link": "https://news.google.com/rss/articles/CBMiigFBVV95cUxQdGhWTUZ0YTQwNEt3S2MxckRZY3ZIcWxvUTVoZnluU0hLZl85bW16NVd6NWRlbXVLRUpuU2tzWDlTSTJ5TXcwRFFiYk0wTF9nT1BweXB0RmdTb1cyejFZNDQ5OVdtTE5XUGNpRm9aVFRrVl80M2VNMFQ3XzBDZHNCemhmbHA0T1J0Rnc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiigFBVV95cUxQdGhWTUZ0YTQwNEt3S2MxckRZY3ZIcWxvUTVoZnluU0hLZl85bW16NVd6NWRlbXVLRUpuU2tzWDlTSTJ5TXcwRFFiYk0wTF9nT1BweXB0RmdTb1cyejFZNDQ5OVdtTE5XUGNpRm9aVFRrVl80M2VNMFQ3XzBDZHNCemhmbHA0T1J0Rnc?oc=5\" target=\"_blank\">J&amp;J builds case for earlier Tecvayli use in multiple myeloma</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">pharmaphorum</font>",
      "published": "2026-01-15T14:09:02+00:00",
      "source": "pharmaphorum"
    },
    {
      "title": "Looking Into Johnson & Johnson's Recent Short Interest - Benzinga",
      "link": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPQVJ0SVA0Ql9RRGhHQ0owRXRVSG5ubU5zTWdLaXg4TUNUbHppYXFIcDkxNGxUN25wTllaZlF1T0FzNktQbW5yS0pJTmM5V1BTRDBKdGJkNmJQcVpxRW9vQzk2emY1MlF1WVRTX3d1MGQzX1Myd01rVU40c0pHX2JIMDMyMFVWb2ptcnRvZ0UySVlxR0N6dkpIN2xfSGpyUU9vYXI1ZE1FR3FPQ0t0VzJ1Q0RCSkM?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMitAFBVV95cUxPQVJ0SVA0Ql9RRGhHQ0owRXRVSG5ubU5zTWdLaXg4TUNUbHppYXFIcDkxNGxUN25wTllaZlF1T0FzNktQbW5yS0pJTmM5V1BTRDBKdGJkNmJQcVpxRW9vQzk2emY1MlF1WVRTX3d1MGQzX1Myd01rVU40c0pHX2JIMDMyMFVWb2ptcnRvZ0UySVlxR0N6dkpIN2xfSGpyUU9vYXI1ZE1FR3FPQ0t0VzJ1Q0RCSkM?oc=5\" target=\"_blank\">Looking Into Johnson & Johnson's Recent Short Interest</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Benzinga</font>",
      "published": "2026-01-14T16:00:29+00:00",
      "source": "Benzinga"
    },
    {
      "title": "Tecvayli tops standard drugs in early multiple myeloma, J&J says - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQTzMwNnJsRU5ZUUo4d3ZlYkNQckRtVE4xN0pvUlFPY1Nlb2pwM2p2b18zbFpwdkVRUHRmejBueGRpQnQ3TFVBaXZxdzJHcXdSS0pLYXlOVU0yNnJoY0paZkNxbVVkN1Y4SnU2ZDJ3MjBsMjhoMnVvaG03d3NreFVWOVBiX21fNlRvVmtzcm9UcFROeHc2a1RiYUJvSGJDWFpoc3RNLWU5X25tQ0k?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQTzMwNnJsRU5ZUUo4d3ZlYkNQckRtVE4xN0pvUlFPY1Nlb2pwM2p2b18zbFpwdkVRUHRmejBueGRpQnQ3TFVBaXZxdzJHcXdSS0pLYXlOVU0yNnJoY0paZkNxbVVkN1Y4SnU2ZDJ3MjBsMjhoMnVvaG03d3NreFVWOVBiX21fNlRvVmtzcm9UcFROeHc2a1RiYUJvSGJDWFpoc3RNLWU5X25tQ0k?oc=5\" target=\"_blank\">Tecvayli tops standard drugs in early multiple myeloma, J&amp;J says</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2026-01-15T16:52:30+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "J&J strengthens case for earlier Tecvayli use in myeloma - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxObmlWVWZjZFAtWlhhVjJJLVBJN2VIQ05WV2NmcGtyUXBCXzZNUzBMNDhyZXR4bTItVldiMUt2MWVUdWppQWVZeHExeXVYSDRZWFkwaW1kOFRVMmYtOXdHNXRxNmNEVUlqWjdOc0JDZmdSdElXaWVtLXcxcVB1N0ZBcFZmRk9iNmtRRXBFLTZURjJ2MHBpN1k1ajBkZl9JLTdvNWRJ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiowFBVV95cUxObmlWVWZjZFAtWlhhVjJJLVBJN2VIQ05WV2NmcGtyUXBCXzZNUzBMNDhyZXR4bTItVldiMUt2MWVUdWppQWVZeHExeXVYSDRZWFkwaW1kOFRVMmYtOXdHNXRxNmNEVUlqWjdOc0JDZmdSdElXaWVtLXcxcVB1N0ZBcFZmRk9iNmtRRXBFLTZURjJ2MHBpN1k1ajBkZl9JLTdvNWRJ?oc=5\" target=\"_blank\">J&amp;J strengthens case for earlier Tecvayli use in myeloma</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2026-01-15T11:59:49+00:00",
      "source": "The Pharma Letter"
    }
  ],
  "product_launches": [
    {
      "title": "JPM26: J&J leans on immunology launches to fuel annual growth - Pharmaceutical Technology",
      "link": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQbUN1UWR5ekpLSl8teGFtdnhpZnhRX2FGM3FpMmxzQjRTZllJX19nQ1IxOGxFejdLam03cjlHeFkwQ1BIOHVHTUFIeHBESlJrTTlNUXRXZ0twblJwb0hTaDROSzJ0YXVxZVd1b29JVmcyNS1pUm1kcWM0YTFxRnFFRE9wMzUyNWpuX0tZblczdkJrMEJMcDBpWk44ejl4MVVhYkhFWm5UVEZuYU0?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQbUN1UWR5ekpLSl8teGFtdnhpZnhRX2FGM3FpMmxzQjRTZllJX19nQ1IxOGxFejdLam03cjlHeFkwQ1BIOHVHTUFIeHBESlJrTTlNUXRXZ0twblJwb0hTaDROSzJ0YXVxZVd1b29JVmcyNS1pUm1kcWM0YTFxRnFFRE9wMzUyNWpuX0tZblczdkJrMEJMcDBpWk44ejl4MVVhYkhFWm5UVEZuYU0?oc=5\" target=\"_blank\">JPM26: J&amp;J leans on immunology launches to fuel annual growth</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Pharmaceutical Technology</font>",
      "published": "2026-01-13T15:50:46+00:00",
      "source": "Pharmaceutical Technology"
    },
    {
      "title": "JNJ.DE Johnson & Johnson (XETRA) €186.76 intraday on 16 Jan 2026: watch earnings due 21 Jan - Meyka",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPSUhIV25BQ2Zaa1B1Nl9hdXk2UWR2YUR0b3UwbzBGQnB5Njh6QWdVRHE0MUdKU0JUVTkyWjlESVpVZ0xZdmxyMDJ5SlBKWkxIMGVYYmlPd053SXNRTUVJTWdWVDdXRjZtVlFQYnBoNDdWNDZsaktDb1FSVjJCRzIxdEdDTF9lVC0xRXQ1WGtHeVVadjFsVl90REM4bmtEQlBQejJxdHU1cFFiX0NzZ1NqeVBB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxPSUhIV25BQ2Zaa1B1Nl9hdXk2UWR2YUR0b3UwbzBGQnB5Njh6QWdVRHE0MUdKU0JUVTkyWjlESVpVZ0xZdmxyMDJ5SlBKWkxIMGVYYmlPd053SXNRTUVJTWdWVDdXRjZtVlFQYnBoNDdWNDZsaktDb1FSVjJCRzIxdEdDTF9lVC0xRXQ1WGtHeVVadjFsVl90REM4bmtEQlBQejJxdHU1cFFiX0NzZ1NqeVBB?oc=5\" target=\"_blank\">JNJ.DE Johnson & Johnson (XETRA) €186.76 intraday on 16 Jan 2026: watch earnings due 21 Jan</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Meyka</font>",
      "published": "2026-01-16T09:58:34+00:00",
      "source": "Meyka"
    },
    {
      "title": "With Two Partnered Launches Expected In 2026, Protagonist Looks To Next Chapter - Citeline News & Insights",
      "link": "https://news.google.com/rss/articles/CBMi_wFBVV95cUxOSklZWHdoN0pPSEhZTEJGa2RtOUFPVGFpTUJXRW5Ic2lpQTY1NHhPdHVyQlhkQzBvRThTMm5LMVhNNDQtdk52MW9BeEVBeTBLMXNlbG5SNXI4SncwUGRKUDdyT3l5a3hvSkFoUExBcklvaHVRZlNlOHJwU0VnTTRGc0xoTW5xdENDNUdSUGVvRG9RaUw4OUNjNnNacHpTNms1Ul9XYXhFeXVlMHR4VDlsTWFDSnJKajhaQlNpZGxqUVJ4ZmpKdjdoUENYa3BlNTNPR0J3QkEwY2JfOXlwdFpzcS1FY2pDQkdKbmNoVmdYd29DS1FucjdSVWRldFJpV1k?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi_wFBVV95cUxOSklZWHdoN0pPSEhZTEJGa2RtOUFPVGFpTUJXRW5Ic2lpQTY1NHhPdHVyQlhkQzBvRThTMm5LMVhNNDQtdk52MW9BeEVBeTBLMXNlbG5SNXI4SncwUGRKUDdyT3l5a3hvSkFoUExBcklvaHVRZlNlOHJwU0VnTTRGc0xoTW5xdENDNUdSUGVvRG9RaUw4OUNjNnNacHpTNms1Ul9XYXhFeXVlMHR4VDlsTWFDSnJKajhaQlNpZGxqUVJ4ZmpKdjdoUENYa3BlNTNPR0J3QkEwY2JfOXlwdFpzcS1FY2pDQkdKbmNoVmdYd29DS1FucjdSVWRldFJpV1k?oc=5\" target=\"_blank\">With Two Partnered Launches Expected In 2026, Protagonist Looks To Next Chapter</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Citeline News & Insights</font>",
      "published": "2026-01-14T15:54:24+00:00",
      "source": "Citeline News & Insights"
    },
    {
      "title": "Key facts: Johnson & Johnson targets growth; CEO announces price deal; no major news at conference - TradingView — Track All Markets",
      "link": "https://news.google.com/rss/articles/CBMi6wFBVV95cUxOWXN0eW1Zc0laUFpZb3BIQXhRaTBCRTRxYWszd2d4TWRYSU9ZYjVqd0VYdnl3ampSSXNlWUxRNk1YcEg4RVBGU0JLSk9OM1lwNHRLOVhham5jQVBMWENUZTN2WUk5a3BoZ2plUWJ1ekJic1VBMW9CcXFrSFE5WEMzb1NPd0NqMnZwN0dVZ2x2QlVkVml5Nko4WFo2Nzl2Zy1FY05ZNzZyWUd2Ykhod0g3eHlLanRNcXdUVnliQzZ1NzVudWpQdkRCZjV3MXBjX1BIOGFjX08ybGYzdFl2M0V4Rklud0g5aFBudXNF?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi6wFBVV95cUxOWXN0eW1Zc0laUFpZb3BIQXhRaTBCRTRxYWszd2d4TWRYSU9ZYjVqd0VYdnl3ampSSXNlWUxRNk1YcEg4RVBGU0JLSk9OM1lwNHRLOVhham5jQVBMWENUZTN2WUk5a3BoZ2plUWJ1ekJic1VBMW9CcXFrSFE5WEMzb1NPd0NqMnZwN0dVZ2x2QlVkVml5Nko4WFo2Nzl2Zy1FY05ZNzZyWUd2Ykhod0g3eHlLanRNcXdUVnliQzZ1NzVudWpQdkRCZjV3MXBjX1BIOGFjX08ybGYzdFl2M0V4Rklud0g5aFBudXNF?oc=5\" target=\"_blank\">Key facts: Johnson & Johnson targets growth; CEO announces price deal; no major news at conference</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TradingView — Track All Markets</font>",
      "published": "2026-01-12T20:03:38+00:00",
      "source": "TradingView — Track All Markets"
    },
    {
      "title": "J&J Gears Up for Some Key New Drug Approvals and Launches - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMickFVX3lxTFBPdUhoMFBEX2lXRzlVb3RUZ1daZkw2Ukt4TEFDSk54S0lrenk5UjNtanp5bXB5YXZiRTBXckFpWkxON0pSYnN5MERDQ3VZY0NNS1A5clE2cndiX3FUdGtkRWx3Zk5faEJoNFBmZ0JGb1FfZw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMickFVX3lxTFBPdUhoMFBEX2lXRzlVb3RUZ1daZkw2Ukt4TEFDSk54S0lrenk5UjNtanp5bXB5YXZiRTBXckFpWkxON0pSYnN5MERDQ3VZY0NNS1A5clE2cndiX3FUdGtkRWx3Zk5faEJoNFBmZ0JGb1FfZw?oc=5\" target=\"_blank\">J&amp;J Gears Up for Some Key New Drug Approvals and Launches</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-09-03T07:00:00+00:00",
      "source": "Yahoo Finance"
    }
  ],
  "stock": {
    "ticker": "JNJ",
    "currency": "USD",
    "latest": {
      "date": "2026-01-15",
      "close": 219.57000732421875
    },
    "history": [
      {
        "date": "2026-01-07",
        "close": 207.49000549316406
      },
      {
        "date": "2026-01-08",
        "close": 205.75
      },
      {
        "date": "2026-01-09",
        "close": 204.38999938964844
      },
      {
        "date": "2026-01-12",
        "close": 209.72000122070312
      },
      {
        "date": "2026-01-13",
        "close": 213.64999389648438
      },
      {
        "date": "2026-01-14",
        "close": 218.5500030517578
      },
      {
        "date": "2026-01-15",
        "close": 219.57000732421875
      }
    ],
    "name": "Johnson & Johnson"
  }
}